Diabetes Mellitus Is Not a Negative Prognostic Factor for Patients Undergoing Hip Arthroscopy
Authors: Perets I, Chaharbakhshi EO, Barkay G, Mu BH, Lall AC, Domb BG
DOI: 10.3928/01477447-20210621-02
Background
Diabetes mellitus (DM) often complicates surgical outcomes, but its effect on hip arthroscopy results is unclear.
Methods
Matched comparison of hip arthroscopy outcomes in patients with and without diabetes undergoing treatment for femoroacetabular impingement (FAI) and labral tears.
Key Findings
- No statistically significant differences in pain relief, functional improvement, or complication rates between diabetic and non-diabetic patients.
- Trends toward slightly worse outcomes in diabetics were not clinically or statistically significant.
Conclusions
DM does not appear to negatively impact hip arthroscopy outcomes for FAI or labral pathology.
What Does This Mean for Providers?
- Diabetes should not be considered a contraindication or a strong negative prognostic factor for hip arthroscopy.
- Providers can counsel diabetic patients that their surgical outcomes are expected to be comparable to those without diabetes.
- Continue standard perioperative management but without undue concern for DM-specific risks affecting hip arthroscopy outcomes.